Department Team Catgegory: Department Of Medicine
-

Dr. Pradeep D’Costa
A prospective, multicentre, randomised, active-controlled, observer-blind, Phase II study seamlessly followed by a Phase III study to evaluate the safety, tolerability and immunogenicity of the candidate HGCO19 (COVID-19 vaccine) in healthy subjects
-

Dr. Parag Khatavkar
Pulmonary rehabilitation delivered in low resource settings for people with chronic respiratory disease: a 3-arm assessor-blind randomised implementation trial

